ADC Development

Antibody-drug conjugates (ADCs) combine targeted antibody specificity with potent cytotoxic payloads, requiring careful control and characterization. Analysis of conjugation, drug-to-antibody ratio (DAR), and structural integrity is essential throughout development. Our SmartEnzymes™ support in-depth and reliable ADC characterization, while GlyCLICK® enables site-specific conjugation for controlled ADC generation.